Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

  • bluebird bio (NASDAQ:BLUE) shares rose 53.4% to $6.12 during Friday's after-market session. Trading volume for this security closed at 5.0 million, accounting for 206.3% of its average full-day volume over the last 100 days. The company's market cap stands at $437.2 million.
  • Aileron Therapeutics (NASDAQ:ALRN) stock moved upwards by 27.46% to $0.53. The company's market cap stands at $48.1 million.
  • ABVC BioPharma (NASDAQ:ABVC) shares moved upwards by 20.0% to $1.08. The company's market cap stands at $34.8 million.
  • Lixte Biotech Hldgs (NASDAQ:LIXT) shares increased by 10.22% to $0.83. The market value of their outstanding shares is at $13.8 million.
  • Minerva Neurosciences (NASDAQ:NERV) stock rose 8.2% to $0.43. The company's market cap stands at $18.3 million.
  • Oncternal Therapeutics (NASDAQ:ONCT) shares moved upwards by 7.31% to $1.32. The company's market cap stands at $65.2 million.

Losers

  • Alpha Tau Medical (NASDAQ:DRTS) stock decreased by 15.1% to $8.2 during Friday's after-market session. The company's market cap stands at $561.5 million.
  • Elevation Oncology (NASDAQ:ELEV) stock decreased by 11.96% to $1.62. The market value of their outstanding shares is at $37.6 million.
  • Acurx Pharmaceuticals (NASDAQ:ACXP) shares fell 7.43% to $3.49. The market value of their outstanding shares is at $35.8 million.
  • Stealth BioTherapeutics (NASDAQ:MITO) shares fell 7.15% to $0.26. The market value of their outstanding shares is at $19.1 million.
  • ViewRay (NASDAQ:VRAY) shares declined by 6.82% to $2.6. The company's market cap stands at $469.1 million.
  • Zosano Pharma (NASDAQ:ZSAN) shares fell 6.75% to $0.52. The market value of their outstanding shares is at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.